Production (Stage)
D
STAAR Surgical Company STAA
$18.68 -$0.09-0.48% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/28/2025 12/27/2024 09/27/2024 06/28/2024 03/29/2024
Net Income -54.21M -34.23M 9.98M 7.38M -3.34M
Total Depreciation and Amortization 2.34M 2.38M 1.76M 1.52M 1.24M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 16.74M 6.92M 10.37M 10.20M 6.96M
Change in Net Operating Assets 29.40M 25.58M -18.29M -29.51M 16.82M
Cash from Operations -5.73M 642.00K 3.82M -10.41M 21.68M
Capital Expenditure -1.47M -5.73M -6.23M -6.24M -5.20M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 36.82M -13.77M -29.01M -14.43M 21.39M
Cash from Investing 35.35M -19.50M -35.24M -20.67M 16.19M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -42.00K -41.00K -42.00K -42.00K -40.00K
Issuance of Common Stock 377.00K 40.00K 1.66M 372.00K 5.33M
Repurchase of Common Stock -1.28M -109.00K 0.00 -167.00K -1.23M
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -948.00K -110.00K 1.62M 163.00K 4.06M
Foreign Exchange rate Adjustments 286.00K -881.00K 1.04M -330.00K -937.00K
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 28.96M -19.84M -28.77M -31.25M 40.99M